Cervical cancer therapies: Current challenges and future perspectives

LATEST ARTICLES
SEARCH INDEX
SUGGEST ARTICLE
THE OSI COLLECTIONS
AUDIOGRAM SERIES
ABOUT THE OSI
2020 SUMMARY
2021 SUMMARY

OSI STATISTICS

Open access articles:
1382
Annotations added:
3
Countries represented:
117
No. of contributors:
13
Bookmarks made:
25

Cervical cancer therapies: Current challenges and future perspectives


JournalTumour Virus Research
Article typeJournal research article – Clinical research
Publication date – Apr – 2022
Authors – Carly A. Burmeister, Saif F. Khan, Georgia Schafer, Nomonde Mbatani, Tracey Adams, Jennifer Moodley, Sharon Prince
Keywordscervical cancer, Combination therapy, HPV E6/E7 oncoproteins, HPV therapeutic Vaccines, Immune checkpoint inhibitors, Targeted therapy
Open access – Yes
SpecialityObstetrics and Gynaecology, Surgical oncology
World region Global

Language – English
Submitted to the One Surgery Index on May 3, 2022 at 11:50 pm
Abstract:

Cervical cancer is the fourth most common female cancer worldwide and results in over 300 000 deaths globally. The causative agent of cervical cancer is persistent infection with high-risk subtypes of the human papillomavirus and the E5, E6 and E7 viral oncoproteins cooperate with host factors to induce and maintain the malignant phenotype. Cervical cancer is a largely preventable disease and early-stage detection is associated with significantly improved survival rates. Indeed, in high-income countries with established vaccination and screening programs it is a rare disease. However, the disease is a killer for women in low- and middle-income countries who, due to limited resources, often present with advanced and untreatable disease. Treatment options include surgical interventions, chemotherapy and/or radiotherapy either alone or in combination. This review describes the initiation and progression of cervical cancer and discusses in depth the advantages and challenges faced by current cervical cancer therapies, followed by a discussion of promising and efficacious new therapies to treat cervical cancer including immunotherapies, targeted therapies, combination therapies, and genetic treatment approaches.

OSI Number – 21586

Public annotations on this article:
No public annotations yet